日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells

抗人TIGIT激动剂抗体通过抑制Tfh和Tph细胞并增强Treg细胞改善自身免疫性疾病

Marenori Kojima, Katsuya Suzuki, Masaru Takeshita, Masaki Ohyagi, Mana Iizuka, Humitsugu Yamane, Keiko Koga, Taku Kouro, Yoshiaki Kassai, Tomoki Yoshihara, Ryutaro Adachi, Kentarou Hashikami, Yuichiro Ota, Keiko Yoshimoto, Yuko Kaneko, Rimpei Morita, Akihiko Yoshimura, Tsutomu Takeuchi

Anti-centromere antibodies target centromere-kinetochore macrocomplex: a comprehensive autoantigen profiling

抗着丝粒抗体靶向着丝粒-着丝粒大复合物:全面的自身抗原分析

Nobuhiko Kajio, Masaru Takeshita, Katsuya Suzuki, Yukari Kaneda, Humitsugu Yamane, Kazuhiro Ikeura, Hidekazu Sato, Shin Kato, Hiroyuki Shimizu, Kazuyuki Tsunoda, Tsutomu Takeuchi

Antigen-driven selection of antibodies against SSA, SSB and the centromere 'complex', including a novel antigen, MIS12 complex, in human salivary glands

人类唾液腺中针对 SSA、SSB 和着丝粒“复合物”(包括一种新型抗原 MIS12 复合物)的抗原驱动抗体选择

Takeshita, Masaru; Suzuki, Katsuya; Kaneda, Yukari; Yamane, Humitsugu; Ikeura, Kazuhiro; Sato, Hidekazu; Kato, Shin; Tsunoda, Kazuyuki; Arase, Hisashi; Takeuchi, Tsutomu

JAK2 V617F-dependent upregulation of PU.1 expression in the peripheral blood of myeloproliferative neoplasm patients

JAK2 V617F 依赖的骨髓增生性肿瘤患者外周血 PU.1 表达上调

Tamotsu Irino, Munehiro Uemura, Humitsugu Yamane, Shigeto Umemura, Takahiko Utsumi, Naoki Kakazu, Taku Shirakawa, Mitsuhiro Ito, Takayo Suzuki, Kazuo Kinoshita